by GlobeNewsWire | Sep 20, 2017 | Globe Newswire
SAN CARLOS, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced the pricing of an...
by GlobeNewsWire | Sep 20, 2017 | Globe Newswire
EL SEGUNDO, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) — Griffin Capital Company, LLC (“Griffin Capital”) announced today the follow-on offering for Griffin Capital Essential Asset REIT II, Inc. (“GCEAR”) was declared effective by the SEC as of September 20, 2017....
by GlobeNewsWire | Sep 20, 2017 | Globe Newswire
ADVISORY, Sept. 20, 2017 (GLOBE NEWSWIRE) — What: Rolex Central Park Horse Show will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Mark Bellissimo, Founder of Rolex Central Park Horse Show, will ring the Closing Bell. Where:Nasdaq...
by GlobeNewsWire | Sep 20, 2017 | Globe Newswire
VANCOUVER, British Columbia, Sept. 20, 2017 (GLOBE NEWSWIRE) — Romulus Resources Ltd. (NEX:ROM.H) (“Romulus” or the “Company”), is pleased to announce it has entered into a non-binding letter of intent dated as of September 20, 2017 (the “LOI”)...
by GlobeNewsWire | Sep 20, 2017 | Globe Newswire
DANVERS, Mass., Sept. 20, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced it has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the...